Diagnostics for the Real World Ltd

Diagnostics for the Real World Ltd specializes in two primary categories of medical devices: non-evacuated urine specimen containers for in vitro diagnostic (IVD) use without additives, and rapid point-of-care (POC) tests. The urine containers are designed for straightforward specimen collection, while the POC tests detect infectious diseases like SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) on-site. These devices are developed to address urgent diagnostic needs in clinical and home settings.

Diagnostics for the Real World Ltd is based in the United States. Due to its location, the company’s devices are listed in the FDA’s Unique Device Identifier (UDI) database, which is a U.S.-specific registry for tracking medical devices. Additionally, some of its devices are also listed in the EU’s EUDAMED registry, indicating their availability or use in the European market, though the company itself is not based in the EU. This dual listing reflects the global reach of its products.

The devices produced by Diagnostics for the Real World Ltd are classified as either Class B or Class I medical devices. Class I devices generally pose minimal risk and often require less regulatory oversight, while Class B devices involve a slightly higher risk level, necessitating additional scrutiny to ensure safety and performance. The classification is determined by factors like the device’s intended use, potential risks, and the duration of contact with the body, as defined by regulatory bodies like the FDA and EU authorities.

The devices manufactured by Diagnostics for the Real World Ltd are listed in two key regulatory registries: the EU’s EUDAMED system and the FDA’s Unique Device Identifier (UDI) database. EUDAMED is the European Union’s medical device registry, used for tracking devices marketed within the EU, while the FDA’s UDI database is the official U.S. system for identifying medical devices through a standardized identification system. These listings help ensure transparency and traceability of the devices in their respective markets.